- Home
- SVRA vs FRPH Comparison
SVRA vs FRPH Comparison
Compare SVRA & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRA | FRPH |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 435.3M |
| IPO Year | 2009 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SVRA | FRPH |
|---|---|---|
| Price | $5.20 | $21.12 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 52.3K |
| Earning Date | 03-13-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | ★ $41,774,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $430.87 | N/A |
| P/E Ratio | ★ N/A | $134.13 |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $1.89 | $21.46 |
| 52 Week High | $7.01 | $29.68 |
Technical Indicators
Market Signals| Indicator | SVRA | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 23.08 |
| Support Level | $5.10 | N/A |
| Resistance Level | $6.10 | $24.59 |
| Average True Range (ATR) | 0.27 | 0.63 |
| MACD | -0.05 | -0.25 |
| Stochastic Oscillator | 24.90 | 3.98 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).